Clinical Scorecard: Decreases in Epicardial Fat and Mediastinal Adipose Tissue Correlate with Enhanced Cardiac Function
At a Glance
Category
Detail
Condition
Severe obesity-associated cardiac dysfunction linked to epicardial adipose tissue (EAT) and mediastinal fat (MF) accumulation
Key Mechanisms
EAT and MF accumulation contribute to left ventricular wall thickening, impaired diastolic performance, and cardiac hypertrophy via increased fat volume, hyperinsulinemia, and hyperleptinemia
Target Population
Adults aged 18–65 years with severe obesity (BMI > 35 kg/m2) and at least one obesity-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea) resistant to medical treatment
Care Setting
Multidisciplinary bariatric surgery center with surgical and metabolic follow-up capabilities
Key Highlights
Epicardial adipose tissue (EAT) and mediastinal fat (MF) volumes decrease significantly after laparoscopic sleeve gastrectomy (LSG)
Reduction in EAT and MF correlates with improved left ventricular ejection fraction and diastolic function parameters
Comprehensive metabolic and cardiac function assessments pre- and post-LSG enable evaluation of fat volume impact on cardiac performance
Guideline-Based Recommendations
Diagnosis
Assess severe obesity patients with BMI > 35 kg/m2 and obesity-related comorbidities for cardiac risk factors
Measure epicardial adipose tissue and mediastinal fat volumes using CT imaging with standardized Hounsfield unit ranges
Evaluate cardiac function via echocardiography including left ventricular ejection fraction and diastolic function parameters
Management
Consider laparoscopic sleeve gastrectomy (LSG) for eligible patients to reduce adipose tissue volumes and improve cardiac function
Implement multidisciplinary care involving surgeons, endocrinologists, and cardiologists for perioperative and postoperative management
Monitor metabolic parameters including insulin resistance, lipid profile, and inflammatory markers to assess systemic improvements
Monitoring & Follow-up
Perform baseline and 1-year postoperative assessments of EAT, MF, visceral and subcutaneous fat areas via CT
Conduct serial echocardiographic evaluations to monitor left ventricular systolic and diastolic function
Track weight loss parameters including total weight loss percentage (%TWL), BMI, and body weight
Risks
Potential for incomplete follow-up and data loss impacting longitudinal assessment
Surgical risks associated with LSG including staple line complications and need for multidisciplinary perioperative care
Cardiac function impairment may persist if adipose tissue reduction is insufficient or comorbidities are uncontrolled
Patient & Prescribing Data
Japanese adults with severe obesity undergoing laparoscopic sleeve gastrectomy
LSG leads to significant reductions in epicardial and mediastinal fat volumes, correlating with improved cardiac systolic and diastolic function at 1-year follow-up
Clinical Best Practices
Use standardized CT imaging protocols and software (e.g., SYNAPSE VINCENT) for accurate quantification of EAT and MF
Apply comprehensive echocardiographic parameters including Simpson method for ejection fraction and diastolic dysfunction algorithms
Ensure multidisciplinary team involvement from initial evaluation through 1-year postoperative follow-up for optimal metabolic and cardiac outcomes
A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.
